Raw Data Library
About
Aims and ScopeAdvisory Board Members
More
Who We Are?
User Guide
Green Science
​
​
EN
Kurumsal BaşvuruSign inGet started
​
​

About
Aims and ScopeAdvisory Board Members
More
Who We Are?
User GuideGreen Science

Language

Kurumsal Başvuru

Sign inGet started
RDL logo

Verified research datasets. Instant access. Built for collaboration.

Navigation

About

Aims and Scope

Advisory Board Members

More

Who We Are?

Contact

Add Raw Data

User Guide

Legal

Privacy Policy

Terms of Service

Support

Got an issue? Email us directly.

Email: info@rawdatalibrary.netOpen Mail App
​
​

© 2026 Raw Data Library. All rights reserved.
PrivacyTermsContact
  1. Raw Data Library
  2. /
  3. Publications
  4. /
  5. [P1–362]: DIAGNOSTIC UTILITY OF FDG‐PET TO CONFIRM A CLINICAL SUSPICION OF AMYOTROPHIC LATERAL SCLEROSIS

Verified authors • Institutional access • DOI aware
50,000+ researchers120,000+ datasets90% satisfaction
Article
en
2017

[P1–362]: DIAGNOSTIC UTILITY OF FDG‐PET TO CONFIRM A CLINICAL SUSPICION OF AMYOTROPHIC LATERAL SCLEROSIS

0 Datasets

0 Files

en
2017
Vol 13 (7S_Part_8)
Vol. 13
DOI: 10.1016/j.jalz.2017.06.378

Get instant academic access to this publication’s datasets.

Create free accountHow it works

Frequently asked questions

Is access really free for academics and students?

Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.

How is my data protected?

Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.

Can I request additional materials?

Yes, message the author after sign-up to request supplementary files or replication code.

Advance your research today

Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.

Get free academic accessLearn more
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaboration
Access Research Data

Join our academic network to download verified datasets and collaborate with researchers worldwide.

Get Free Access
Institutional SSO
Secure
This PDF is not available in different languages.
No localized PDFs are currently available.
Massimo Filippi
Massimo Filippi

Institution not specified

Verified
Daniele Altomare
Stefania Orini
Federica Agosta
+4 more

Abstract

We performed a systematic review to assess the available evidence of FDG-PET utility in the diagnosis of Amyotrophic Lateral Sclerosis (ALS) with and without cognitive impairment. The search was performed on Medline, Embase and Cochrane on November 20, 2015. Critical outcomes for this PICO are sensitivity, specificity and accuracy of FDG-PET in distinguishing patients with ALS from patients with other pathologies or healthy people, as assessed versus clinical diagnosis. Minimum sample size was set at 10 subjects with the target condition. Data were extracted and assessed as to publication bias, heterogeneity, imprecision, risk of bias, indirectness, and applicability. We provide assessment of the quality of evidence, of the target effect, and of strength of recommendation. Out of the 16 papers selected, 2 reported the outcomes of interest. These provided moderate quality of evidence (Table) that hypometabolic regions including the prefrontal cortex, thalamus, primary motor cortex, striatum and posterior cingulate can distinguish ALS patients from healthy controls with 94.8–95.4% sensitivity, 80.0–82.5% specificity and 91.8–93.2% accuracy (Laere et al., 2014; and Pagani et al., 2014). Concerns regarding the applicability of FDG-PET as assessed here are due to the use of semiquantitative methods of image analysis (increasingly but not yet routinely adopted in clinical context). The available data provide moderate quality of evidence for high diagnostic utility of FDG-PET in distinguishing ALS patients from healthy controls. However, all studies were performed considering baseline clinical diagnosis as the reference standard, raising doubt on either methodological validity or the actual clinical usefulness of FDG-PET in improving clinical diagnosis. We conclude for a doubtful recommendation for clinical use of FDG-PET in the diagnosis of ALS. Further research is warranted to provide proper assessment of the incremental value of FDG-PET on this issue.

How to cite this publication

Daniele Altomare, Stefania Orini, Federica Agosta, Elisabetta Sarasso, Cristina Festari, Massimo Filippi, Marina Boccardi (2017). [P1–362]: DIAGNOSTIC UTILITY OF FDG‐PET TO CONFIRM A CLINICAL SUSPICION OF AMYOTROPHIC LATERAL SCLEROSIS. , 13(7S_Part_8), DOI: https://doi.org/10.1016/j.jalz.2017.06.378.

Related publications

Why join Raw Data Library?

Quality

Datasets shared by verified academics with rich metadata and previews.

Control

Authors choose access levels; downloads are logged for transparency.

Free for Academia

Students and faculty get instant access after verification.

Publication Details

Type

Article

Year

2017

Authors

7

Datasets

0

Total Files

0

Language

en

DOI

https://doi.org/10.1016/j.jalz.2017.06.378

Join Research Community

Access datasets from 50,000+ researchers worldwide with institutional verification.

Get Free Access